The main primary care database held by the Clinical Practice Research Datalink (CPRD) is known as CPRD GOLD (formerly known as the General Practice Research Database, or GPRD). CPRD GOLD contains the anonymised, longitudinal medical records of patients registered with contributing primary care practices across the United Kingdom.<\/p>
<\/p>
<\/p>
<\/p>
The CPRD GOLD database covers approximately 8.8% of the UK population, including practices in England, Northern Ireland, Scotland and Wales. As of September 2014 there were 684 general practitioner (GP) practices and 13.58 million acceptable (research quality) patients in GOLD, of which 5.69 million are active (still alive and registered with the GP practice). Data has been collected from GP practices since 1987.<\/p>
<\/p>
<\/p>
<\/p>
A review of the CPRD GOLD database has identified the a total of 15,248 acceptable (research quality) patients with at least one record of pneumococcal disease in CPRD GOLD over the period 1 January 1987 to 30 September 2014 during their up-to-standard registration period. Of these patients, 14,150 had at least one record of pneumococcal pneumonia and 491 patients had at least one record of pneumococcal meningitis.<\/p>
<\/p>
<\/p>
<\/p>
Over the period 1 October 2013 to 30 September 2014, there were a total of 473 acceptable (research quality) patients with at least one record of pneumococcal disease during their up-to-standard registration period. Of these patients; 445 had a record of pneumococcal pneumonia and 14 had at least one record of pneumococcal meningitis.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2014-11-06", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-06T13:15:07.2719615Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pneumococcal Disease"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what proportion of people have records contained in the General Practice Research Database; how many patients whose records are in the Database have at least one record of pneumococcal disease (a) in total and (b) in the last year for which figures are available; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/308", "label" : {"_value" : "Biography information for Mr Jim Cunningham"} } , "tablingMemberConstituency" : {"_value" : "Coventry South"} , "tablingMemberPrinted" : [{"_value" : "Mr Jim Cunningham"} ], "uin" : "213015"} , {"_about" : "http://data.parliament.uk/resources/105985", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/105985/answer", "answerText" : {"_value" : "
The following tables show the percentage who received the pneumococcal vaccinations (PPV) in that financial year, and the percentage of people 65 years and over who have ever received PPV vaccine.<\/p>
<\/p>
<\/p>
<\/p>
Percentage of those aged 65 years+ vaccinated against PPV in each of last five years:<\/p>
<\/p>
<\/p>
<\/p>
Period vaccinated<\/p><\/td> | Percentage of >=65 years received PPV vaccine<\/p><\/td> | <\/p><\/td> | Period vaccinated<\/p><\/td> | Percentage of >=65 years received PPV vaccine<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From 1 April 2008 to 31 March 2009<\/p><\/td> | 4.1%<\/p><\/td> | <\/p><\/td> | Anytime up to 31 March 2009<\/p><\/td> | 68.2%<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From 1 April 2009 to 31 March 2010<\/p><\/td> | 3.9%<\/p><\/td> | <\/p><\/td> | Anytime up to 31 March 2010<\/p><\/td> | 69.4%<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From 1 April 2010 to 31 March 2011<\/p><\/td> | 3.8%<\/p><\/td> | <\/p><\/td> | Anytime up to 31 March 2011<\/p><\/td> | 70.5%<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From 1 April 2011 to 31 March 2012<\/p><\/td> | 3.6%<\/p><\/td> | <\/p><\/td> | Anytime up to 31 March 2012<\/p><\/td> | 68.3%<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From 1 April 2012 to 31 March 2013<\/p><\/td> | 3.9%<\/p><\/td> | <\/p><\/td> | Anytime up to 31 March 2013<\/p><\/td> | 69.1%<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> There has only been one survey of pneumococcal vaccine uptake for clinical risk groups under 65 years of age which was undertaken in 2009. The proportion who had received vaccine in the financial year (1 April 2008 to 31 March 2009) was 3.7%. The cumulative vaccine uptake for those in a clinical at risk group aged 2 to 65 years up and until 31 March 2009 (i.e. those who had received pneumococcal vaccine at any time up to that date) was 53.0%.<\/p> <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2014-11-06", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-06T17:31:16.7060995Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pneumococcal Disease"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what proportion of people in defined at risk groups who were eligible for pneumococcal vaccinations were vaccinated against pneumococcal disease in each of the last five year for which figures are available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/308", "label" : {"_value" : "Biography information for Mr Jim Cunningham"} } , "tablingMemberConstituency" : {"_value" : "Coventry South"} , "tablingMemberPrinted" : [{"_value" : "Mr Jim Cunningham"} ], "uin" : "213014"} , {"_about" : "http://data.parliament.uk/resources/105987", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/105987/answer", "answerText" : {"_value" : " Data for England and Wales are analysed six months after the end of the reporting year based on laboratory confirmed reports of invasive pneumococcal disease (IPD) and the results of serotyping.<\/p> <\/p> <\/p> <\/p> The data provided below relates to the total number of IPD cases in England and Wales for all ages up to June 2013 with serotypes that are in the current Pneumococcal Conjugate Vaccine-13 (PCV-13) vaccine recommended in the childhood schedule and which are potentially preventable. PCV-13, which was introduced in 2010, is routinely offered to children aged two, four and 12 months.<\/p> <\/p> <\/p> <\/p> Number of IPD cases for all ages, up to June 2013:<\/p> <\/p> <\/p> <\/p>
|